Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Core EBITDA Growth

    Back to All Ratios
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 18.691.19-0.11-4.0759.14

What is the latest Core EBITDA Growth ratio of VENUS REMEDIES ?

The latest Core EBITDA Growth ratio of VENUS REMEDIES is 18.69 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202518.69
Mar20241.19
Mar2023-0.11
Mar2022-4.07
Mar202159.14

How is Core EBITDA Growth of VENUS REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2025 18.69
1,470.59
Mar2024 1.19
Positive
Mar2023 -0.11
Negative
Mar2022 -4.07
Negative
Mar2021 59.14 -

Other Financial Ratios of VENUS REMEDIES


Compare Core EBITDA Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹1,023.1 Cr 0.2% 70.1% 128% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,753.0 Cr -0.2% 6.1% 0.3% Stock Analytics
DIVIS LABORATORIES ₹167,998.0 Cr -1.4% -4.9% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,186.0 Cr 0.8% 5% 12.9% Stock Analytics
CIPLA ₹120,960.0 Cr -1.3% -0.5% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,759.0 Cr -0.7% 5.1% 4.9% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

0.2%

70.1%

128%

SENSEX

-0.6%

2.2%

5.3%


You may also like the below Video Courses